Our Upcoming Event: FIP World Congress 2026

🇨🇦 One Health, One Pharmacy, One Mission. International Pharmaceutical Federation (FIP) World Congress 2026. 🌍

We are excited to share that our CEO, Irena Milobratovic, will be an active participant at the 84th FIP World Congress in Montreal, August 30 – September 2, 2026.

This year, we will contribute four poster presentations to the NextGen Precision Oncology discussion, with a regulatory science focus.

If you’re attending, we’d love to connect! ✨

À bientôt, Montréal! 🇨🇦

Our FIP 2026 podcast

BioMeld Project

In this video, we unpack the BioMeld Project and explore the promise of a modular framework in biohybrid machines. We’ll look at its proof of concept, the paradigm shift it represents, and the benefits it could bring to the medical technology field.

Prof. Dr. Igor Balaz, from the University of Novi Sad, Faculty of Agriculture, CEO @ Neovivum, and Project Coordinator of BioMeld, will help us understand the deep-tech concept behind the project.

Biohybrid innovation is opening new possibilities at the intersection of biology, engineering, and medicine - and this is just the beginning.

CancerScan Project

In this video, we unpack CancerScan smart pathology slide scanners for diagnosis and patient-specific treatment recommendations in oncology. The CancerScan Project is exploring how patient-derived organoids, AI-powered tumour digital twins, and advanced imaging technologies could contribute to more personalised treatment decisions for pancreatic cancer.

Prof. Dr. Igor Balaz, CEO of Neovivum and innovator behind the CancerScan Digital Twin System, offers a deeper look into the technology and the regulatory-by-design perspective behind the CancerScan project.

Drug-Repurposing Project

In this video, we explore a drug-repurposing approach investigating the potential of sulfonylureas, a class of medicines used in diabetes for more than half a century, in oncology. Modern nanoliposome technologies may offer new opportunities to combine synergistic medicines with very different pharmacokinetic profiles, opening interesting possibilities for innovative therapeutic strategies.

Dr. Mateusz Tomczyk from Silesian University of Technology, the innovator behind the Drug-Repurposing Project, shares his journey from research to development and gives valuable insights into the combination strategy, its formulation, and the proof of concept.

NAMs Project

In this video, we unpack New Approach Methodologies, or NAMs, and their growing role in modern biomedical research in developing more human-relevant approaches to understanding diseases and innovating new therapies and technologies. We look beyond the individual technologies and explore why the shift towards NAMs is happening, what traditional animal models cannot fully answer, and how combining different experimental and computational approaches can generate stronger scientific evidence.